[1]
Ravasio, R. and Migliore, A. 2020. Economic evaluation of low-dose SKA cytokines in patients with rheumatoid arthritis in maintaining low disease activity or remission. AboutOpen. 7, 1 (Sep. 2020), 67–73. DOI:https://doi.org/10.33393/abtpn.2020.2153.